title: Development of obsessive symptoms during nefazodone treatment.
authors.forename: M
authors.initials: M
authors.lastname: Sofuoglu
authors.forename: C
authors.initials: C
authors.lastname: Debattista
mesh_terms: D000328:Adult; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects*; D003866:Depressive Disorder / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D009771:Obsessive-Compulsive Disorder / Q000139:chemically induced*; D010879:Piperazines; D014230:Triazoles / Q000009:adverse effects*
chemical_list: D018687:Antidepressive Agents, Second-Generation; D010879:Piperazines; D014230:Triazoles; C051752:nefazodone